Top Markets
#1 Ontology Gas Ontology Gas +49.08%
#2 Verus Coin Verus Coin +22.51%
#3 EXOD EXOD +22.08%
#4 Status Status +20.01%
#5 ETHGas ETHGas +18.84%
#6 Geodnet Geodnet +16.73%
#7 The Black Bull The Black Bull +13.40%
#8 Fake World Assets Fake World Assets +11.29%
#9 Derive Derive +11.24%
#10 Ontology Ontology +9.41%
Coin of the day
Ontology Gas Ontology Gas
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
ATyr Pharma, Inc. ATyr Pharma, Inc.

ATyr Pharma, Inc.

ATYR
Classificação em ações #25448
aTyr Pharma, Inc., a biopharmaceutical firm established in San Diego,... aTyr Pharma, Inc., a biopharmaceutical firm established in San Diego, California, in 2005, is dedicated to the discovery and advancement of therapeutic solutions. Operating within the United States, the company's research focuses on pioneering novel immunological pathways to address various medical conditions. Its primary investigational drug, efzofitimod, functions as a selective modulator of NRP2. This compound is currently undergoing a Phase III clinical trial for pulmonary sarcoidosis. Additionally, efzofitimod is being evaluated in a Phase 1b/2a clinical study for the treatment of other interstitial lung diseases (ILDs), including conditions such as chronic hypersensitivity pneumonitis and ILDs linked to connective tissue diseases. Beyond its lead candidate, aTyr Pharma's pipeline features ATYR0101, a fusion protein derived from a domain of aspartyl-tRNA synthetase, which is in preclinical stages of development for combating fibrosis. The company is also progressing with ATYR0750, a domain sourced from alanyl-tRNA synthetase, intended for the management of liver disorders. Furthermore, aTyr Pharma has entered into a strategic collaboration and licensing agreement with Kyorin Pharmaceutical Co., Ltd. This partnership is focused on the development and commercialization of efzofitimod for interstitial lung diseases specifically within the Japanese market.
Preço da ação
$0.5049
Última sincronização: 2026-08-20
Valor de mercado
$49.51M
Variação (1 dia)
-5.24%
Variação (1 ano)
-89.80%
País
US
Negociar ATyr Pharma, Inc. (ATYR)

Categoria

Healthcare
Histórico de preços das ações de ATyr Pharma, Inc. (ATYR)
Preço de fecho mais alto: $0.53 em 2026-08-01

Preço de fecho mais baixo: $1.73 em 2024-05-01
Histórico de preços das ações da ATyr Pharma, Inc. de 2024 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2026 (TTM) 37.71%
2025 -77.30%
2024 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $539.14 35.65%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.04K 56.21%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $117.78 -18.87%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $761.87 8.65%
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $130.43 397.46%
US